Indian Orthopedic Biomaterials Markets by Market Reports on India Market Reports on India presents the report on "Indian Orthopedic Biomaterials Markets” is expected to reach $71.6 million by 2019. Feb 14, 2015 – Navi Mumbai, India: Market Reports on India presents the report on "Indian Orthopedic Biomaterials Markets" It is expected to reach $71.6 million by 2019. The bone graft substitute segment constitutes the majority of the Indian orthopedic biomaterials market, and is the fastest growing segment. Summary: The Indian orthopedic biomaterials market is expected to reach $71.6 million by 2019. The bone graft substitute segment constitutes the majority of the Indian orthopedic biomaterials market, and is the fastest growing segment. The Indian orthopedic biomaterials market comprises autologous bone grafts, bone graft substitutes (segmented into allografts, synthetics and demineralized bone matrices) and hyaluronic acid (HA) viscosupplementation. The overall market is still relatively young in India and is expected to continue to grow as a result of the aging Indian population and as new competitors enter the market. Further growth in the overall market is fuelled by the Indian government’s efforts to improve healthcare coverage across the country, and by the increasing disposable income of Indian citizens. Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for India. Report Contents: Competitor Analysis Identified Strategic Opportunities Market Overview by Segment & Country Trend Analysis by Segment & Country Market Drivers & Limiters Mergers & Acquisitions Customer Feedback and Market Monitoring Main Markets Included: Orthopedic Biomaterials Bone Graft Substitutes Hyaluronic Acid Viscosupplementation Sub-Segments Included: Growth Factors Bone Graft Substitutes Hyaluronic Acid Viscosupplementation Autograft Non-Proprietary Allograft Demineralized Bone Matrix Synthetic Markets by Indication Single-Injection Products Three-Injection Cycle Products